Genetics testing services supplier Veritas is set to acquire fellow Boston-based start-up Arvados for an undisclosed sum, according to anonymous insiders. Under the deal, Arvados, which has developed an open-source platform called Curoserve to store, manage and analyse genomic data, will continue to operate as a standalone business. The purchase is with a view to scaling up Veritas's abilities so it will be able to analyse thousands and even eventually millions of genomes a month. Wellcome Trust Sanger Institute and IBM Watson are among the firms already using Curoserve.
Genetics testing services supplier Veritas is set to acquire fellow Boston-based start-up Curoserve for an undisclosed sum, according to anonymous insiders. Under the deal, Curoserve, which has developed an open-source platform called Arvados to store, manage and analyse genomic data, will continue to operate as a standalone business. The purchase is with a view to scaling up Veritas's abilities so it will be able to analyse thousands and even eventually millions of genomes a month. Wellcome Trust Sanger Institute and IBM Watson are among the firms already using Arvados.